Key result
PFM-guided slow pathway ablation links to ~11 mm greater distance from the His bundle vs conventional approach.
Why the study?
Slow pathway ablation for AVNRT is constrained by proximity to the His bundle, limiting procedural safety margins, whereas peak frequency mapping may enable safer ablation farther away.
Does PFM-guided slow pathway ablation improve procedural safety margins and clinical efficacy compared to the conventional anatomical approach in patients with typical AVNRT?
Cohort (n=81)
Does PFM-guided slow pathway ablation improve procedural safety margins and clinical efficacy compared to the conventional anatomical approach in patients with typical AVNRT?
Peak frequency mapping-guided slow pathway ablation allows for safer lesion delivery further from the His bundle while maintaining high acute success and long-term efficacy in AVNRT patients.
Answers are grounded in this paper and cite their sources.
May facilitate safer annular ablation in AVNRT; leaves open confirmation of reduced complications versus conventional mapping.
BACKGROUND: Although slow pathway ablation is an established curative therapy for typical atrioventricular nodal reentrant tachycardia (AVNRT), lesion delivery is constrained by the anatomical proximity to the His bundle, limiting the procedural safety margin. Peak frequency mapping (PFM) is a novel physiology-based method that highlights regions of the slow pathway-related electrograms and may enable safer ablation at more annular sites. OBJECTIVE: To evaluate the reproducibility, procedural safety, and clinical efficacy of PFM-guided slow pathway ablation compared with the conventional anatomical approach. METHODS: Eighty-one consecutive patients with typical AVNRT were analyzed (39 conventional, 42 PFM-guided). Procedural characteristics, acute success, safety outcomes, and mid-term recurrence were assessed. RESULTS: PFM consistently localized the slow pathway around the 4-5 o'clock region of the tricuspid annulus and enabled effective ablation at significantly greater distances from the His bundle (22.8 ± 5.5 vs. 11.5 ± 3.2 mm, p < 0.0001). Acute success was achieved in all PFM-guided cases and in 97.4% of conventional cases. PFM-guided ablation required fewer RF applications and demonstrated earlier and slower junctional rhythm during energy delivery. During a mean follow-up of 822 ± 362 days, recurrence occurred in 2 conventional patients (5.1%) but in none of the PFM-guided patients. CONCLUSIONS: PFM-guided slow pathway ablation enables lesion delivery at annular sites farther from the His bundle while maintaining acute success and mid-term efficacy. By facilitating ablation at sites more distant from the His bundle, this physiology-based strategy may provide a wider procedural safety margin and represents a reproducible refinement of conventional AVNRT ablation.
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (2026) conducted a cohort in Typical atrioventricular nodal reentrant tachycardia (AVNRT) (n=81). Peak frequency mapping (PFM)-guided slow pathway ablation vs. Conventional anatomical approach was evaluated on Distance from the His bundle during effective ablation (mm) (p=<0.0001). Peak frequency mapping-guided slow pathway ablation enabled effective ablation at greater distances from the His bundle compared to the conventional approach.
Synapse has enriched 10 related papers. Consider them for comparative context: